In 2022, we began developing production technologies for high-purity solvents in response to demand from Russian pharmaceutical and biotechnology companies, laboratories and research institutes. Our first developments yielded premium solvents for chromatography–mass spectrometry that match or exceed the quality of Western equivalents, whose imports had become difficult or stopped altogether.

By 2025, we had developed and begun producing acetonitrile for HPLC and HPLC–MS, as well as ultra-dry acetonitrile for DNA synthesis. We also produce tetrahydrofuran, toluene, isopropanol, hexane, ethyl acetate, acetic acid and dimethyl sulfoxide for HPLC, HPLC–MS and biotechnology. Several more solvents critical to high-tech sectors of Russian chemistry are in development as imports become increasingly difficult amid international instability.